Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease

被引:5
|
作者
Ninni, Sandro [1 ,2 ]
Lemesle, Gilles [1 ,2 ]
Meurice, Thibaud [3 ]
Tricot, Olivier [4 ]
Lamblin, Nicolas [1 ,5 ]
Bauters, Christophe [1 ,5 ]
机构
[1] Univ Lille, Dept Cardiol, CHU Lille, F-59000 Lille, France
[2] Inst Pasteur, U1011, F-59000 Lille, France
[3] Hop Prive Le Bois, F-59003 Lille, France
[4] Ctr Hosp Dunkerque, F-59240 Dunkerque, France
[5] Inst Pasteur, U1167, F-59000 Lille, France
关键词
coronary artery disease; atrial fibrillation; prognosis; anticoagulation; antiplatelet therapy; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; ESC GUIDELINES; HEART-FAILURE; MANAGEMENT; OUTCOMES; DETERMINANTS; PREVALENCE; MORTALITY; RISK;
D O I
10.3390/jcm9082367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:The risk, correlates, and consequences of incident atrial fibrillation (AF) in patients with chronic coronary artery disease (CAD) are largely unknown.Methods and results:We analyzed incident AF during a 3-year follow-up in 5031 CAD outpatients included in the prospective multicenter CARDIONOR registry and with no history of AF at baseline. Incident AF occurred in 266 patients (3-year cumulative incidence: 4.7% (95% confidence interval (CI): 4.1 to 5.3)). Incident AF was diagnosed during cardiology outpatient visits in 177 (66.5%) patients, 87 of whom were asymptomatic. Of note, 46 (17.3%) patients were diagnosed at time of hospitalization for heart failure, and a few patients (n= 5) at the time of ischemic stroke. Five variables were independently associated with incident AF: older age (p< 0.0001), heart failure (p= 0.003), lower left ventricle ejection fraction (p= 0.008), history of hypertension (p= 0.010), and diabetes mellitus (p= 0.033). Anticoagulant therapy was used in 245 (92%) patients and was associated with an antiplatelet drug in half (n= 122). Incident AF was a powerful predictor of all-cause (adjusted hazard ratio: 2.04; 95% CI: 1.47 to 2.83;p< 0.0001) and cardiovascular mortality (adjusted hazard ratio: 2.88; 95% CI: 1.88 to 4.43;p< 0.0001).Conclusions:In CAD outpatients, real-life incident AF occurs at a stable rate of 1.6% annually and is frequently diagnosed in asymptomatic patients during cardiology outpatient visits. Anticoagulation is used in most cases, often combined with antiplatelet therapy. Incident AF is associated with increased mortality.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [21] Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice
    Mazurek, Michal
    Huisman, Menno V.
    Lip, Gregory Y. H.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (02): : 135 - 145
  • [22] Atrial fibrillation and stroke risk prevention in real-life clinical practice
    Tay, Kok Hoon
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 415 - 416
  • [23] DABIGATRAN TROUGH AND PEAK LEVELS IN "REAL-LIFE" PATIENTS WITH ATRIAL FIBRILLATION
    Sinigoj, P.
    Malmstrom, R. E.
    Vene, N.
    Bozic-Mijovski, M.
    Pohanka, A.
    Antovic, J. P.
    Mavri, A.
    [J]. THROMBOSIS RESEARCH, 2016, 141 : S2 - S2
  • [24] Electrical cardioversion for atrial fibrillation: outcomes in 'real-life' clinical practice
    Berry, C
    Stewart, S
    Payne, EM
    McArthur, JD
    McMurray, JJV
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 81 (01) : 29 - 35
  • [25] Diagnosis of obstructive coronary artery disease by cardiogoniometry: A field test in a real-life setting
    Spiliopoulos, Sotirios
    Wald, Christof
    Hergesell, Vera
    Dimitriou, Alexandros Merkourios
    Koerfer, Reiner
    Tenderich, Gero
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2015, 48 (03) : 420 - 422
  • [26] External Validity of the ARISTOTLE Trial in Real-Life Atrial Fibrillation Patients
    Hagg, Lovisa
    Johansson, Cecilia
    Jansson, Jan-Hakan
    Johansson, Lars
    [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (05) : 214 - 218
  • [27] Stroke prevention in atrial fibrillation: evidence from real-life studies
    Akao, Masaharu
    Beyer-Westendorf, Jan
    Goto, Shinya
    Peterson, Eric
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0D) : D42 - D52
  • [28] Atrial fibrillation in coronary artery disease: role of atrial enlargement and ischaemia
    Wang, LX
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (2-3) : 309 - 310
  • [29] Risk markers of incident atrial fibrillation in patients with coronary heart disease
    Tomasdottir, Maria
    Held, Claes
    Hadziosmanovic, Nermin
    Westerbergh, Johan
    Lindback, Johan
    Aylward, Philip E.
    Budaj, Andrzej
    Cannon, Christopher P.
    Engdahl, Johan
    Granger, Christopher B.
    Koenig, Wolfgang
    Manolis, Athanasios J.
    Oldgren, Jonas
    Stewart, Ralph A. H.
    Svennberg, Emma
    Vinereanu, Dragos
    White, Harvey D.
    Siegbahn, Agneta
    Wallentin, Lars
    Hijazi, Ziad
    [J]. AMERICAN HEART JOURNAL, 2021, 233 : 92 - 101
  • [30] Antithrombotic treatment in real-life atrial fibrillation patients:: a report from the Euro Heart Survey on Atrial Fibrillation
    Nieuwlaat, Robby
    Capucci, Alessandro
    Lip, Gregory Y. H.
    Olsson, S. Bertil
    Prins, Martin H.
    Nieman, Fred H.
    Lopez-Sendon, Jose
    Vardas, Panos E.
    Aliot, Etienne
    Santini, Massimo
    Crijns, Harry J. G. M.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (24) : 3018 - 3026